eIF5A is an indispensable protein for eukaryotic cells

Technical Summary: eIF5A is an Indispensable Protein for Eukaryotic Cells

Problem Statement
eIF5A is an evolutionarily conserved translation elongation factor essential for eukaryotic life, involved in ribosomal elongation, ribosome quality control, and the synthesis of specific proteins (e.g., formins, collagen). In most eukaryotes, including Saccharomyces cerevisiae and humans, eIF5A is encoded by two paralogous genes: a highly expressed, essential copy (TIF51A/EIF5A1) and a second, largely silent copy (TIF51B/EIF5A2) that is repressed under aerobic conditions. While many essential genes possess paralogous backups that compensate for loss-of-function mutations, the essentiality of TIF51A suggests the second copy does not provide a classical genetic backup. The study aims to identify genetic mechanisms that can suppress the lethality caused by temperature-sensitive mutations in the essential TIF51A gene, thereby elucidating the functional constraints of eIF5A and the regulatory mechanisms governing its paralogue.

Methodology
The researchers employed a genetic suppressor screen in S. cerevisiae using two temperature-sensitive (ts) mutant strains of TIF51A (tif51A-1 and tif51A-3), which exhibit growth defects at restrictive temperatures (37°C).

1. Suppressor Isolation: Spontaneous suppressors were isolated from two genetic backgrounds: one retaining the paralogous TIF51B gene and one where TIF51B was deleted (tif51BΔ).
2. Phenotypic Characterization: Suppressor colonies were tested for growth restoration at restrictive temperatures (37°C and 40°C) and on respiratory media (glycerol).
3. Molecular Analysis:
   • Protein Analysis: Western blotting using antibodies specific to Tif51A, Tif51B, and hypusinated eIF5A was performed to assess protein levels and stability (using cycloheximide chase assays).
   • Genomic Sequencing: Whole-genome sequencing (WGS) and Sanger sequencing were used to identify mutations in suppressor strains.
   • Gene Expression: RT-qPCR and Chromatin Immunoprecipitation (ChIP) assays quantified mRNA levels and RNA Polymerase II binding at the TIF51B promoter.
   • Structural Modeling: AlphaFold2 was used to predict 3D structures of mutant proteins (Tif51A, Rox1, Mot3), and stability changes were calculated using I-Mutant2.0.
   • Genome Editing: CRISPR/Cas9 was utilized to introduce specific point mutations in ROX1 and MOT3 into parental strains to validate their role as suppressors.

Key Results

1. Suppression via TIF51B Derepression: In the presence of the TIF51B gene, suppressors of tif51A mutations arose at a frequency of ~10⁻⁶. All isolated suppressors contained mutations in the transcriptional repressors ROX1 or MOT3. These mutations (SNPs in the DNA-binding HMG domain of Rox1 or frameshifts in ROX1 and MOT3) led to the derepression and upregulation of the silent TIF51B gene. The resulting Tif51B protein compensated for the unstable Tif51A protein at restrictive temperatures.
2. Specificity of Repression: The study demonstrated that Rox1 and Mot3 act synergistically to repress TIF51B. Mutations in these repressors did not cause a global derepression of all hypoxic genes; rather, the effect was specific to genes with specific binding site configurations. TIF51B possesses multiple high-affinity binding sites for both repressors, making it highly sensitive to their dysfunction.
3. Lethality in the Absence of the Backup: When TIF51B was deleted (tif51BΔ background), the frequency of suppressor emergence dropped 13- to 25-fold (to ~10⁻⁷). Crucially, no suppressors were found that compensated for the loss of eIF5A function via mutations in other genes or pathways. Instead, all surviving suppressors were either:
   • Revertants: Restoring the original wild-type amino acid sequence.
   • Intragenic Suppressors: Acquiring new point mutations within the TIF51A coding sequence (e.g., D72Y) that restored protein stability without reverting the original mutation.
4. Protein Stability: Structural modeling confirmed that the original ts mutations (P83S, C39Y, G118D) reduced protein stability. The intragenic suppressor mutations (e.g., D72Y) compensated for this instability, allowing the protein to fold correctly and function at restrictive temperatures.
5. Overexpression Toxicity: Exogenous overexpression of TIF51B in wild-type cells (where TIF51A is active) resulted in a slight growth defect, suggesting that strict repression of the second copy is necessary to prevent deleterious effects of eIF5A overexpression.

Significance and Claims
The paper concludes that eIF5A is an indispensable protein in eukaryotic cells. Its essential function cannot be bypassed by mutations in other proteins or alternative pathways. The study establishes that:

• The paralogous TIF51B gene serves as a "non-conventional backup system" that operates at the population level rather than the cellular level. It does not provide immediate feedback compensation within a cell; instead, cell populations survive by selecting for rare mutations that derepress the silent copy.
• The strict repression of TIF51B by Rox1 and Mot3 is a critical regulatory mechanism to prevent the toxicity of eIF5A overexpression while maintaining the capacity for rapid adaptation if the primary copy fails.
• The essentiality of eIF5A is intrinsic to its specific role in the ribosome, likely related to its unique hypusination and interaction with stalled ribosomes, a function that cannot be substituted by other translation factors or ribosomal components.

These findings expand the understanding of gene duplication dynamics, highlighting that while paralogs can buffer essential functions, the mechanism may rely on population-level selection rather than immediate cellular compensation. Furthermore, the results underscore the irreplaceable nature of eIF5A, with implications for understanding diseases linked to eIF5A dysregulation, such as cancer, diabetes, and neurodevelopmental disorders.